DURHAM, N.C., April 20, 2017 — Premier Research’s Chief Medical Officer will lead a panel discussion on patient-centric research on April 20 at the World Orphan Drug Congress (WODC) in Washington, D.C.
Dr. Colin Hayward will examine what patient-centricity means and where it’s taking the clinical research industry, joined by panelists Jayne Gershkowitz of Amicus Therapeutics, Michelle Hylan of Innov8tive Research Consulting, Juliet Moritz of Premier Research, and Julie Walters of Raremark.
Premier Research is a sponsor of WODC 2017 and of this year’s Pitch and Partner event, where biotech and pharma companies involved in orphan drug development describe their plans in 10-minute presentations to inform and entice capital and research partners.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.